Questions: Viral Pneumonia: Host Immune Response, Cytotoxicity, and Secondary Infection

Question 1

In severe viral pneumonia, the most direct cause of hypoxemia (dangerously low blood oxygen) is:

• A. Decreased cardiac output, reducing blood delivery to pulmonary capillaries
• B. Direct viral infection of red blood cells, impairing their oxygen-carrying capacity
• C. Alveolar flooding by inflammatory exudate, creating perfused but unventilated alveoli (V/Q mismatch)
• D. Bronchospasm from viral toxins physically blocking the large airways

Answer: (C)

Inflammatory exudate — fluid, fibrin, macrophages, and neutrophils — fills the alveolar space, replacing air with liquid. These flooded alveoli remain perfused by pulmonary capillaries but are not ventilated (no gas exchange possible). This ventilation-perfusion (V/Q) mismatch is the direct mechanism of hypoxemia: blood passes through the lung but encounters no oxygen in the alveoli. Reduced cardiac output and bronchospasm can worsen the picture but are not the primary mechanism. Viruses do not meaningfully infect red blood cells in pneumonia.

Question 2

A patient recovering from influenza suddenly develops new fever, productive cough, and lobar consolidation on chest X-ray five days after the initial illness. The most likely explanation is:

• A. The influenza virus mutated to a more pathogenic strain during replication
• B. A cytokine storm driven by the innate immune response to influenza causing new consolidation
• C. Secondary bacterial superinfection exploiting mucociliary damage and transiently suppressed local immunity
• D. Autoimmune pneumonitis triggered by cross-reactive antibodies against lung tissue

Answer: (C)

Secondary bacterial superinfection — classically Streptococcus pneumoniae, Staphylococcus aureus, or Haemophilus influenzae — is the classic explanation for this pattern. Influenza disrupts three key defenses: (1) mucociliary clearance is impaired by damaged ciliated epithelium; (2) type I interferon responses transiently suppress antimicrobial defenses; (3) viral injury exposes basement membrane proteins bacteria can adhere to. The bacteria superimpose a second inflammatory insult on already damaged tissue. This mechanism explains the historically lethal secondary bacterial pneumonias seen in the 1918 influenza pandemic.

Question 3

In viral pneumonia, the immune response is purely protective — cytotoxic T cells eliminate the virus without contributing to lung tissue damage.

• T. True
• F. False

Answer: False

Cytotoxic CD8+ T cells (CTLs) are essential for viral clearance: they recognize virally infected cells presenting viral peptides on MHC class I and kill them via perforin/granzyme. But they cannot distinguish cells that have already completed viral replication from those still in early infection — they kill any infected alveolar cell. This amplifies epithelial destruction beyond what the virus alone would cause. In severe cases, inflammatory cytokines (IL-6, TNF-α, IFN-γ) from activated T cells and macrophages drive cytokine storm and ARDS, representing immune-mediated injury far exceeding the viral cytopathic effect.

Question 4

The loss of type II pneumocytes is particularly damaging in viral pneumonia because these cells produce surfactant, and without surfactant, smaller alveoli tend to collapse due to elevated surface tension.

• T. True
• F. False

Answer: True

Type II pneumocytes (cuboidal alveolar epithelial cells) are the primary producers of pulmonary surfactant, the phospholipid film that reduces surface tension at the air-liquid interface. Without surfactant, Laplace's law predicts that smaller alveoli (which have higher surface tension relative to their radius) will collapse (atelectasis). This loss of lung compliance — the lung becomes stiffer and harder to inflate — is the earliest mechanical consequence of type II pneumocyte death and a key driver of the increased work of breathing in viral pneumonia.

Question 5

Why is cytotoxic T cell (CTL) activity described as a 'double-edged sword' in the context of viral pneumonia?

Model answer: CTLs are essential for viral clearance: they recognize and kill cells presenting viral peptides on MHC I, eliminating viral replication factories. Without them, the virus would spread unchecked. But CTLs cannot distinguish infected cells that have already released virus from those still in early infection — they destroy any virally infected alveolar cell. Since the alveolar epithelium is the structural surface required for gas exchange, CTL-mediated killing amplifies the epithelial destruction, worsening V/Q mismatch and hypoxemia. The immune mechanism required to clear the infection simultaneously accelerates the structural damage causing respiratory failure.

This double-edged nature is most visible in severe COVID-19 and influenza: patients with very strong CD8+ T cell responses can develop ARDS not primarily from viral replication but from immune-mediated lung injury. The clinical implication is that immunomodulatory therapies (like corticosteroids) can reduce immune-mediated damage even while the antiviral response continues.